CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0
Read more about CPHI
24
Jun
2025

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

Exhibitor at CPHI & PMEC China 2025 stand E3D98, Pharma Excipients
About Us

Founded in 2013, Heron Pharma is a pharmaceutical company adhering to an innovation-driven and product differentiation strategy. lt possesses world-leading research and development technology for active vitamin D derivatives, NCEs and first generics. The bulk production of active vitamin D derivative drugs can be provided over the world, including Alfacalcidol, Calcipotriol, Calcifediol, Calcitriol, Eldecalcitol, Doxercalciferol, Maxacalcitol, Paricalcitol, Tacalcitol, etc.

Over the past decade, 8 FDFs have been successfully commercialized in China, including the ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2019
    On CPHI since
  • 1 - 24
    Employees
Company types
Distributor/Import Export
View company profile
Contact info
  • +86 150 2187 4276
  • Website
  • Room 1903, Building 20, No. 1679 Yuqiao Road, Pudong New Area District,, 201204, Shangai, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2025
  • 24 Jun 2025 - 26 Jun 2025
  • Shanghai New International Expo Center
  • Visit us at stand E3D98, Pharma Excipients

Products Featured at CPHI & PMEC China 2025

  • Calcifediol

    Product Calcifediol

    in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia.
  • Maxacalcitol

    Product Maxacalcitol

    produced under GMP conditions, indicated for Secondary hyperparathyroidism and Psoriasis
  • Calcitriol

    Product Calcitriol

    Calcitriol (骨化三醇)  in compliance with BP/USP/EP monographs, produced under GMP conditions, indicated for Rickets, Osteoporosis, Hypoparathyroidism, Renal osteodystrophy and Osteomalacia.
  • Alfacalcidol

    Product Alfacalcidol

    Alfacalcidol (阿法骨化醇) is in compliance with the monographs of EP/BP/ChP Grade, produced under GMP conditions and indicated for Osteoporosis, Chronic renal insufficiency, Hypoparathyroidism, Vitamin D-resistant rickets and Osteomalacia.
  • Calcipotriol monohydrate

    Product Calcipotriol monohydrate

    EP/BP Grade, produced under GMP conditions, indicated for Psoriasis Vulgaris.

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd. Resources (1)

  • Heron Pharma Interview

    Video Heron Pharma Interview

    Heron Pharmaceutical Science & Technology Co., Ltd. was founded in 2013 and grew fast in the past 6 years. Chuangye Jiangsu 8090+ interviewed Heron Pharma on July 4th, 2019 since this company is one successful case of New Born Company in Nanjing City. This video could help more people to understand Heron Pharma and know more interest details how we work.
    2019-10-08

Recently Visited